SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist
A. Bozonnat, Florence Assan, Jérôme LeGoff, E. Bourrat, H. Bachelez
Topics & Concepts
Interleukin 1 receptor antagonistMedical microbiologyImmunologyMedicineMutationReceptorInterleukinReceptor antagonistAntagonistVirologyBiologyCytokineInternal medicineGeneGeneticsCytokine Signaling Pathways and InteractionsAdrenal Hormones and Disordersinterferon and immune responses